Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-01

Clinical Trial Update: Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure [NA]

View source ↗

Summary

A clinical trial evaluating email reminders to improve GDMT adherence for mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)
  • eplerenone (eplerenone)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Heart Failure With Reduced Ejection Fraction | NA | Status: WITHDRAWN